Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease | Zendy

Christina Wyatt | Zendy; Detlef Schlöndorff | Zendy

Open Access

Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease

Author(s) -

Christina Wyatt,

Detlef Schlöndorff

Publication year - 2016

Publication title -

kidney international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.499

H-Index - 276

eISSN - 1523-1755

pISSN - 0085-2538

DOI - 10.1016/j.kint.2016.02.009

Subject(s) - precision medicine , nephrology , disease , medicine , kidney disease , identification (biology) , pathognomonic , intensive care medicine , bioinformatics , pathology , biology , botany

The goal of "precision medicine" is to characterize diseases based on the underlying molecular biology, in order to identify specific biomarkers and therapeutic targets that will ultimately improve clinical outcomes. The nephrology research community has developed a strong foundation for precision medicine, and recent publications demonstrate the feasibility of this approach to identify potential biomarkers and therapeutic targets in chronic kidney disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research